Christophe Caux

11PUBLICATIONS
118CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCellular immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 14, 2025
Dendritic cells: the central partner for cancer immunity.

Léo Laoubi, Elisa Gobbini, Pierre Duplouye

|Jun 25, 2025
Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors.

Philippe A Cassier, Mitesh J Borad, Sunil Sharma

|May 16, 2025
Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial.

Laetitia Collet, Maude Ardin, David Venet

|Jan 08, 2025
The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma.

Elisa Gobbini, Margaux Hubert, Anne-Claire Doffin

|Aug 21, 2024
KIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer.

Sara Santagata, Anna Maria Trotta, Crescenzo D'Alterio

|Apr 02, 2024
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer.

Guilhem Lalle, Raphaëlle Lautraite, Khaled Bouherrou

Pageof 2

Frequent Collaborators

6 joint publications

Bertrand Dubois

4 joint publications

Margaux Hubert

4 joint publications

Justine Berthet

3 joint publications

Jenny Valladeau-Guilemond